| Supplementary Protection Certificate (SPC) Summary | |||||||||
| SPC No. | 2015/053 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of filing | 21/10/2015 | ||||||||
| Notification of Application Published | 18/11/2015 | ||||||||
| Status | Granted | ||||||||
| Notification of Grant Published | 21/02/2018 | ||||||||
| Date of Expiry of SPC | 27/11/2026 | ||||||||
| Applicant |
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY Barnahely Ringaskiddy Co Cork IRELAND |
||||||||
| Patent Number | 1663240 | ||||||||
| Title of Invention | COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS | ||||||||
| Date of Expiry of Patent | 02/09/2024 | ||||||||
| Product Type | Medicinal Product | ||||||||
| Product Identity | A combination of rilpivirine or a pharmaceutically acceptable salt thereof, including the hydrochloride salt, tenofovir, in particular tenofovir disoproxil fumarate, and emtricitabine | Market Authorisation | Ireland | European Union | |||||
| Authorisation No | EU/1/11/737/001-002 | EU/1/11/737/001-002 | |||||||
| Authorisation Date | 28/11/2011 | 28/11/2011 | |||||||
| Identity of Product Authorised | Eviplera - emtricitabine/rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate) | Eviplera - emtricitabine/rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate) | |||||||
| Address for Service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||||||||
| Renewal Fees |
|
||||||||
| 01/02/2018 | Supplementary Protection Certificate Number 2015/053, having an expiry date of 27/11/2026 granted on 01/02/2018. | ||||||||
| 31/05/2023 | Change of name and address of applicant(s) from JANSSEN SCIENCES IRELAND UC, Eastgate Village, Eastgate, Little Island, Cork, Ireland to JANSSEN SCIENCES IRELAND UNLIMITED COMPANY, Barnahely, Ringaskiddy, Co Cork, Ireland recorded on 23/05/2023. | ||||||||